PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2016 | 6 | 3 | A118-121
Article title

“Life-saving” inappropriate implantable cardioverter-defibrillator shocks in a cancer patient

Content
Title variants
Languages of publication
EN
Abstracts
EN
Impaired left ventricular ejection fraction (LVEF) in patients with cancer can disqualify them from targeted antineoplastic treatment. We present the case of 63-year-old male with gastric cancer treated palliatively, with concomitant dilated cardiomyopathy, atrial fibrillation (AF) and after implantation of a cardioverter-defibrillator (ICD), in whom inappropriate ICD discharges caused unexpected return of sinus rhythm and significant LVEF improvement, what subsequently led to reclassification to targeted chemotherapy. In conclusion, unexpected return of sinus rhythm in cancer patients with AF and reduced LVEF may lead to LVEF recovery and enable the use of antineoplastic treatment with improved prognosis.
Discipline
Publisher

Journal
Year
Volume
6
Issue
3
Pages
A118-121
Physical description
Contributors
author
  • Department of Cardiology, St. Queen Jadwiga District Hospital No. 2, Rzeszow, Poland; Invasive Cardiology Department, St. Joseph’s Heart Centre, Rzeszow, Poland, piotr.futyma@gmail.com
  • Rev. Bronislaw Markiewicz Subcarpathian Oncology Centre, Brzozow, Poland
  • Department of Cardiology, St. Queen Jadwiga District Hospital No. 2, Rzeszow, Poland
  • Department of Cardiology, St. Queen Jadwiga District Hospital No. 2, Rzeszow, Poland
References
  • 1. van Rees JB, Borleffs CJ, de Bie MK et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57(5): 556-562.
  • 2. Powell BD, Saxon LA, Boehmer JP et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol 2013; 62(18): 1674- 1679.
  • 3. Przybylski A, Sterliński M, Lewandowski M et al. Risk of thromboembolic complications in patients with permanent atrial fibrillation undergoing cardioverter-defibrillator implantation. Kardiol Pol 2002; 57(10): 306-312.
  • 4. Lee DS, Krahn AD, Healey JS. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 2010; 55(8): 774-782.
  • 5. Futyma M, Chudzik M, Wranicz JK et al. Atrial fibrillation in implantable cardioverter-defibrillator patients. Cardiol J 2005; 12(10): 706-712.
  • 6. ESC Guidelines for the Management of Atrial Fibrillation of 2012. Kardiol Pol 2012; 70(4): 197-234.
  • 7. Lelakowski J, Tomala I, Ćmiel A et al. Predictors of sinus rhythm return during defibrillation testing in patients with permanent atrial fibrillation undergoing implantation of a cardioverter-defibrillator. Kardiol Pol 2011; 69(1): 17-22.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-85f696c6-3212-4f76-9abd-6d904738fade
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.